Opposing reactions in coenzyme A metabolism sensitize Mycobacterium tuberculosis to enzyme inhibition
Author(s) -
Elaine Ballinger,
John Mosior,
Travis Hartman,
Kristin Burns-Huang,
Ben Gold,
Roxanne Morris,
Laurent Goullieux,
Isabelle Blanc,
Julien Vaubourgeix,
Sophie Lagrange,
Laurent Fraisse,
Stéphanie Sans,
Cédric Couturier,
Eric Bacqué,
Kyu Y. Rhee,
Sarah M. Scarry,
Jeffrey Aubé,
Guangbin Yang,
Ouathek Ouerfelli,
Dirk Schnappinger,
Thomas R. Ioerger,
Curtis A. Engelhart,
Jennifer A. McConnell,
Kathrine McAulay,
Allison Fay,
Christine Roubert,
James C. Sacchettini,
Carl Nathan
Publication year - 2019
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.aau8959
Subject(s) - mycobacterium tuberculosis , enzyme , metabolism , microbiology and biotechnology , chemistry , cofactor , biochemistry , coenzyme a , mycobacterium , tuberculosis , biology , medicine , reductase , pathology
Mycobacterium tuberculosis (Mtb) is the leading infectious cause of death in humans. Synthesis of lipids critical for Mtb's cell wall and virulence depends on phosphopantetheinyl transferase (PptT), an enzyme that transfers 4'-phosphopantetheine (Ppt) from coenzyme A (CoA) to diverse acyl carrier proteins. We identified a compound that kills Mtb by binding and partially inhibiting PptT. Killing of Mtb by the compound is potentiated by another enzyme encoded in the same operon, Ppt hydrolase (PptH), that undoes the PptT reaction. Thus, loss-of-function mutants of PptH displayed antimicrobial resistance. Our PptT-inhibitor cocrystal structure may aid further development of antimycobacterial agents against this long-sought target. The opposing reactions of PptT and PptH uncover a regulatory pathway in CoA physiology.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom